- Home
- SGMO vs ONL Comparison
SGMO vs ONL Comparison
Compare SGMO & ONL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- ONL
- Stock Information
- Founded
- SGMO 1995
- ONL 2021
- Country
- SGMO United States
- ONL United States
- Employees
- SGMO N/A
- ONL N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- ONL Real Estate Investment Trusts
- Sector
- SGMO Health Care
- ONL Real Estate
- Exchange
- SGMO Nasdaq
- ONL Nasdaq
- Market Cap
- SGMO 122.8M
- ONL 169.5M
- IPO Year
- SGMO 2000
- ONL N/A
- Fundamental
- Price
- SGMO $0.51
- ONL $2.94
- Analyst Decision
- SGMO Strong Buy
- ONL Hold
- Analyst Count
- SGMO 7
- ONL 1
- Target Price
- SGMO $5.29
- ONL N/A
- AVG Volume (30 Days)
- SGMO 5.2M
- ONL 328.4K
- Earning Date
- SGMO 08-07-2025
- ONL 11-06-2025
- Dividend Yield
- SGMO N/A
- ONL 2.64%
- EPS Growth
- SGMO N/A
- ONL N/A
- EPS
- SGMO N/A
- ONL N/A
- Revenue
- SGMO $81,706,000.00
- ONL $151,869,000.00
- Revenue This Year
- SGMO $21.24
- ONL N/A
- Revenue Next Year
- SGMO N/A
- ONL N/A
- P/E Ratio
- SGMO N/A
- ONL N/A
- Revenue Growth
- SGMO 565.52
- ONL N/A
- 52 Week Low
- SGMO $0.41
- ONL $1.46
- 52 Week High
- SGMO $3.18
- ONL $4.39
- Technical
- Relative Strength Index (RSI)
- SGMO 44.92
- ONL 65.19
- Support Level
- SGMO $0.47
- ONL $2.52
- Resistance Level
- SGMO $0.56
- ONL $3.05
- Average True Range (ATR)
- SGMO 0.03
- ONL 0.10
- MACD
- SGMO -0.00
- ONL 0.01
- Stochastic Oscillator
- SGMO 32.31
- ONL 76.74
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About ONL Orion Office REIT Inc.
Orion Properties Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased on a single-tenant net lease basis to creditworthy clients. The portfolio of the company includes traditional office buildings, governmental offices, medical offices, laboratories, and others. The Company operates in one business segment: direct ownership and operation of commercial real estate.